Identification Of Structure Of Apolipoprotein Could Lead To Development Of New Drugs To Treat Obesity, Stroke And Diabetes

Identifying the wrong thing.

Using a sophisticated technique of x-ray crystallography, researchers Xiaohu Mei, PhD, and David Atkinson, PhD, from Boston University School of Medicine (BUSM) have for the first time obtained an "image" of the structure and the precise arrangement of the atoms in a truncated form of the apolipoprotein A-I (apoA-I) molecule. The findings, which appear in the November issue of the Journal of Biological Chemistry, may lead to the development of new drugs to treat obesity, stroke and diabetes.

No need to identify anything other than all overweight/obesity is caused by more Calories in than out.

No drug is needed except for Self-Restraint-inol.